Antibody Combinations In Immunotherapy Offer New Opportunities For Innovators To Strengthen IP Protections - Intellectual Property

Companies have been exploring the potential to use combinations of various checkpoint inhibitors to enhance the treatment of patients with various cancers.

Related Keywords

,Genentech ,Genentech Inc ,Drug Administration Of Bristol Myers Squibb ,Drug Administration ,Bristol Myers Squibb ,Mondaq ,Antibody Therapy ,Iologics ,Immunotherapy ,Pr ,Litigation ,Pdualag ,Tab ,Food ,Drugs ,Healthcare ,Life Sciences ,Iotechnology Amp Nanotechnology ,Intellectual Property ,Patent ,